Kshitij Kumar

As AI agents become embedded in everyday workflows — from healthcare diagnostics to financial services chatbots — the line between human and machine continues to blur. This panel brings together industry leaders to tackle the tough questions: • How do we trust AI agents in high-risk environments? • What are the new rules of ownership and accountability when autonomous systems act on data? • Is AI replacing or enhancing the human workforce — and how do we keep the balance right? We'll unpack how AI agents are evolving across sectors, debate whether the current LLM paradigm is enough, and explore the new guardrails needed to futureproof agentic AI — without losing control.

Recent advancements in cryo-EM enable the routine elucidation of high-resolution structures for use in drug discovery. In this session, Clovertex and KEK discuss how their collaboration on AWS resulted in increased productivity, while reducing the time to create structures and the cost per structure.